Tech Company Financing Transactions
ArgiNOx Pharmaceuticals Funding Round
On 6/30/2006, ArgiNOx Pharmaceuticals raised $1.1 million in funding from Aisling Capital.
Transaction Overview
Company Name
Announced On
6/30/2006
Transaction Type
Venture Equity
Amount
$1,100,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
3 Lagoon Dr. 220
Redwood City, CA 94065
USA
Redwood City, CA 94065
USA
Phone
Website
Email Address
Not Recorded
Overview
Arginox Pharmaceuticals is an emerging specialty biopharmaceutical company focusing on the discovery and development of breakthrough drugs for treating hospitalized patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kenneth Drazan
Browse more venture capital transactions:
Prev: 6/30/2006: Sirigen venture capital transaction
Next: 6/30/2006: Axis Partners venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs